- Home
- CLLS vs SFST Comparison
CLLS vs SFST Comparison
Compare CLLS & SFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- SFST
- Stock Information
- Founded
- CLLS 1999
- SFST 1999
- Country
- CLLS France
- SFST United States
- Employees
- CLLS N/A
- SFST N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- SFST Major Banks
- Sector
- CLLS Health Care
- SFST Finance
- Exchange
- CLLS Nasdaq
- SFST Nasdaq
- Market Cap
- CLLS 299.0M
- SFST 335.4M
- IPO Year
- CLLS 2007
- SFST 1999
- Fundamental
- Price
- CLLS $3.08
- SFST $44.39
- Analyst Decision
- CLLS Buy
- SFST Buy
- Analyst Count
- CLLS 1
- SFST 1
- Target Price
- CLLS $4.00
- SFST $51.00
- AVG Volume (30 Days)
- CLLS 71.4K
- SFST 19.7K
- Earning Date
- CLLS 11-03-2025
- SFST 10-21-2025
- Dividend Yield
- CLLS N/A
- SFST N/A
- EPS Growth
- CLLS N/A
- SFST 58.48
- EPS
- CLLS N/A
- SFST 2.69
- Revenue
- CLLS $63,438,000.00
- SFST $102,878,000.00
- Revenue This Year
- CLLS N/A
- SFST $8.65
- Revenue Next Year
- CLLS $66.76
- SFST $13.43
- P/E Ratio
- CLLS N/A
- SFST $16.28
- Revenue Growth
- CLLS 223.09
- SFST 15.60
- 52 Week Low
- CLLS $1.10
- SFST $29.14
- 52 Week High
- CLLS $3.35
- SFST $46.00
- Technical
- Relative Strength Index (RSI)
- CLLS 62.30
- SFST 53.91
- Support Level
- CLLS $2.88
- SFST $43.79
- Resistance Level
- CLLS $3.20
- SFST $45.36
- Average True Range (ATR)
- CLLS 0.17
- SFST 0.92
- MACD
- CLLS 0.02
- SFST -0.21
- Stochastic Oscillator
- CLLS 68.24
- SFST 27.15
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.